ARTICLE
17 May 2023

Payor/Provider Convergence And What It Means For You

FL
Foley & Lardner

Contributor

Foley & Lardner LLP looks beyond the law to focus on the constantly evolving demands facing our clients and their industries. With over 1,100 lawyers in 24 offices across the United States, Mexico, Europe and Asia, Foley approaches client service by first understanding our clients’ priorities, objectives and challenges. We work hard to understand our clients’ issues and forge long-term relationships with them to help achieve successful outcomes and solve their legal issues through practical business advice and cutting-edge legal insight. Our clients view us as trusted business advisors because we understand that great legal service is only valuable if it is relevant, practical and beneficial to their businesses.
We are excited to announce that this article is the first of a series addressing the intersection of payor/provider convergence and the issues that plague insurance and health companies, payors, and providers.
United States Food, Drugs, Healthcare, Life Sciences

Editor's Note: We are excited to announce that this article is the first of a series addressing the intersection of payor/provider convergence and the issues that plague insurance and health companies, payors, and providers. We will be addressing various considerations including the end of the Public Health Emergency, CMS' innovation models and trends, private equity in the risk bearing space, expansion of coverage for telehealth services and more.

Welcome to the Payor/Provider Convergence Series of the Health Care Law Today blog. This series is dedicated to exploring the intersection between payors and providers in the health care space; in particular, the evolving trend toward value based payment structures. Payors and providers in the health care space both want high quality and cost effective care delivered to their members and patients, and these two groups are finding new ways to achieve their mutual goals.

Health care providers are increasingly taking financial risk in their contracts with health insurance companies and, in turn, health insurance companies are becoming more involved in the delivery of care. As each group begins to take on certain characteristics and responsibilities of the other, it is important that they understand the scope of the laws and rules applicable to them.

For example, health care providers and health insurance companies may enter into payment structures where the insurers pay providers to manage a specific types of care for a group of patients. In a traditional fee for service model, providers bill for each individual service provided to their patient and, as such, providers are financially incentivized to provide extra goods and services. In contrast, in a value-based model, it is up to the provider to manage the funds, which incentivizes providers to deliver the most appropriate care.

Value-based models of care may require providers to obtain an additional level of registration in certain states. Health care providers should be wary of crossing the line into becoming an insurer without understanding the implications and the accompanying regulatory obligations.

On the other side, insurers may need to engage medical professionals to perform medical record reviews and audits of these value based arrangements to accurately measure the quality and value of care provided beyond the review required for a traditional fee for service claim, and to provide effective utilization review and care management.

Even further, some health insurance companies have entered into the business of providing health care themselves by acquiring professional practices, in some cases at significant scale.

Payors and providers must understand the incentive structure of the other, and this series will focus on laws and rules applicable to the intersection of the two. Future topics in this series will include:

  • Medicare Advantage updates (for information on the Medicare Advantage 2023 Final Rule, click here)
  • Implications of the ending Public Health Emergency
  • Risk bearing entities and private equity in the risk bearing space
  • Knox-Keene plan regulations
  • Addressing social determinants of health
  • False Claims Act risk adjustment for payors
  • No Surprises Act developments
  • Expansion of coverage for telehealth
  • CMS's innovation models and trends (e.g. accountable care organizations (ACOs), oncology care models, and Center for Medicare and Medicaid Innovation (CMMI) payment models)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More